Have a personal or library account? Click to login
Inadequate glycemic control among patients with type 2 diabetes in Jordan: prevalence and associated factors Cover

Inadequate glycemic control among patients with type 2 diabetes in Jordan: prevalence and associated factors

Open Access
|Mar 2026

References

  1. Sun H, Saeedi P, Karuranga S, et al. IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045. Diabetes Res Clin Pract. 2022;183:109119.
  2. Emerging Risk Factors Collaboration; Sarwar N, Gao P, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet. 2010;375:2215–2222.
  3. Ajlouni K, Batieha A, Jaddou H, et al. Time trends in diabetes mellitus in Jordan between 1994 and 2017. Diabet Med. 2019;36:1176–1182.
  4. Awad SF, Huangfu P, Dargham SR, et al. Characterizing the type 2 diabetes mellitus epidemic in Jordan up to 2050. Sci Rep. 2020;10:21001.
  5. Hyassat D, Al-Saeksaek S, Naji D, et al. Dyslipidemia among patients with type 2 diabetes in Jordan: prevalence, pattern, and associated factors. Front Public Health. 2022;10:1002466.
  6. American Diabetes Association Professional Practice Committee. 8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of medical care in diabetes-2022. Diabetes Care. 2022;45:S113–S124.
  7. Shita NG, Iyasu AS. Glycemic control and its associated factors in type 2 diabetes patients at Felege Hiwot and Debre Markos Referral Hospitals. Sci Rep. 2022;12:9459.
  8. Al-Qerem W, Jarab AS, Badinjki M, Hammad A, Ling J, Alasmari F. Factors associated with glycemic control among patients with type 2 diabetes: a cross-sectional study. Eur Rev Med Pharmacol Sci. 2022;26:2415–2421.
  9. Almomani MH, Al-Tawalbeh S. Glycemic control and its relationship with diabetes self-care behaviors among patients with type 2 diabetes in Northern Jordan: a cross-sectional study. Patient Prefer Adherence. 2022;16:449–465.
  10. Anioke IC, Ezedigboh AN, Dozie-Nwakile OC, Chukwu IJ, Kalu PN. Predictors of poor glycemic control in adult with type 2 diabetes in South-Eastern Nigeria. Afr Health Sci. 2019;19:2819–2828.
  11. Nduati NJ, Simon K, Eva N, Lawrence M. Factors associated with glycemic control among type 2 diabetes patients attending Mathari National Teaching Hospital, Nairobi Kenya. J Endocrinol Diab. 2016;3:1–11.
  12. Tekalegn Y, Addissie A, Kebede T, Ayele W. Magnitude of glycemic control and its associated factors among patients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia. PLoS One. 2018;13:e0193442.
  13. Badedi M, Solan Y, Darraj H, et al. Erratum to “Factors Associated with Long-Term Control of Type 2 Diabetes Mellitus”. J Diabetes Res. 2019;2019:8756138.
  14. Abera RG, Demesse ES, Boko WD. Evaluation of glycemic control and related factors among outpatients with type 2 diabetes at Tikur Anbessa Specialized Hospital, Addis Ababa, Ethiopia: a cross-sectional study. BMC Endocr Disord. 2022;22:54.
  15. Mobula LM, Sarfo FS, Carson KA, et al. Predictors of glycemic control in type-2 diabetes mellitus: evidence from a multicenter study in Ghana. Transl Metab Synd Res. 2018;1:1–8.
  16. Milo RB, Connelly CD. Predictors of glycemic management among patients with type 2 diabetes. J Clin Nurs. 2019;28:1737–1744.
  17. Mohammad A, Abujbara M, Alshraideh J, Jaddou H, Ajlouni K. The prevalence of resistant hypertension among type 2 diabetic patients attending the national center for diabetes, endocrinology, and genetics. J Endocrinol Metab. 2017;7:153–158.
  18. Zerriouh F, Khader Y. Diabetes in Jordan: prevalence, trend, awareness and control. iproc. 2018;4:e10565.
  19. Al Quran TM, Bataineh ZA, Al-Mistarehi AH, et al. Prevalence and pattern of dyslipidemia and its associated factors among patients with type 2 diabetes mellitus in Jordan: a cross-sectional study. Int J Gen Med. 2022;15:7669–7683.
  20. Association AD. Standards of medical care in diabetes—2019 abridged for primary care providers. Clin Diabetes. 2019;37:11–34.
  21. Sanal T, Nair N, Adhikari P. Factors associated with poor control of type 2 diabetes mellitus: a systematic review and Meta-analysis. J Diabetol. 2011;2:4.
  22. Mamo Y, Bekele F, Nigussie T, Zewudie A. Determinants of poor glycemic control among adult patients with type 2 diabetes mellitus in Jimma University Medical Center, Jimma zone, south west Ethiopia: a case control study. BMC Endocr Disord. 2019;19:91.
  23. Woldu MA, Wami CD, Lenjisa JL, Tegegne GT, Tesafye G, Dinsa H. Factors associated with poor glycemic control among patients with type 2 diabetes mellitus in Ambo Hospital, Ambo; Ethiopia. Endocrinol Metab Synd. 2014:3:143.
  24. Souliotis K, Koutsovasilis A, Vatheia G, et al. Profile and factors associated with glycaemic control of patients with type 2 diabetes in Greece: results from the diabetes registry. BMC Endocr Disord. 2020;20:16.
  25. Parhofer KG. Interaction between glucose and lipid metabolism: more than diabetic dyslipidemia. Diabetes Metab J. 2015;39:353–362.
  26. Jyoti G, Navin K, Mamta S, Seema R, Banwari L, Singh BP. Factors affecting glycemic control among patients with type 2 diabetes at a tertiary health care center of western UP region: a crosssectional study. Int J Health Sci Res. 2019;9: 12–20.
  27. Unnikrishnan R, Anjana RM, Deepa M, et al. Glycemic control among individuals with selfreported diabetes in India - the ICMR-INDIAB study. Diabetes Technol Ther. 2014;16:596–603.
  28. Badedi M, Solan Y, Darraj H, et al. Factors associated with long-term control of type 2 diabetes mellitus. J Diabetes Res. 2016;2016:2109542.
  29. Gebreyohannes EA, Netere AK, Belachew SA. Glycemic control among diabetic patients in Ethiopia: a systematic review and meta-analysis. PLoS One. 2019;14:e0221790.
  30. Yakubu A, Dahiru S, Mainasara AS, Anaja PO, Musa B, Hassan HA. Determinants of poor glycaemic control among type 2 diabetic patients at a suburban tertiary hospital in North-Western Nigeria. Int J Sci Health Res. 2020;5:207–214.
  31. Navarro-Pérez J, Orozco-Beltran D, Gil-Guillen V, et al. Mortality and cardiovascular disease burden of uncontrolled diabetes in a registry-based cohort: t he ESCARVAL-risk study. BMC Cardiovasc Disord. 2018;18:1–9.
  32. Campagna D, Alamo A, Di Pino A, et al. Smoking and diabetes: dangerous liaisons and confusing relationships. Diabetol Metab Syndr. 2019; 11:1–2.
  33. Anan F, Takahashi N, Shinohara T, et al. Smoking is associated with insulin resistance and cardiovascular autonomic dysfunction in type 2 diabetic patients. Eur J Clin Invest. 2006;36:459–465.
DOI: https://doi.org/10.2478/FON-2026-0015 | Journal eISSN: 2544-8994 | Journal ISSN: 2097-5368
Language: English
Page range: 131 - 138
Submitted on: Feb 3, 2025
|
Accepted on: Feb 25, 2025
|
Published on: Mar 24, 2026
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year

© 2026 Abeer Amin Mohammad, Jafar Alshraideh, Mohammed Ibrahim Yacoub, Mohammad A. Abu Sabra, published by Shanxi Medical Periodical Press
This work is licensed under the Creative Commons Attribution 4.0 License.